BioCentury | Aug 3, 2015
Financial News

Ally Bridge Group financial update

...hedge fund will primarily invest in publicly listed Asian healthcare companies, with a focus on China biopharmaceuticals...
BioCentury | Jun 25, 2012
Company News

NeoStem deal

...is subject to shareholder approval. NeoStem acquired its stake in 2009 through its acquisition of China Biopharmaceuticals Holdings Inc....
BioCentury | Nov 9, 2009
Company News

NeoStem, China Biopharmaceuticals deal

...NeoStem acquired China Biopharmaceuticals, which owns 51% of Suzhou Erye Pharmaceutical Co. Ltd. (Suzhou, China). Suzhou Erye...
...its stem cell therapy, research and development in China. NeoStem Inc. (NYSE-A:NBS), New York, N.Y. China Biopharmaceuticals Holdings Inc....
BioCentury | Oct 15, 2007
Company News

Beijing Med-Pharm management update

Beijing Med-Pharm Corp. (BJGP), Plymouth Meeting, Penn. Business: Supply/Service Hired: Yanping Zhao as corporate VP, formerly VP, executive director and chief representative of the Beijing office at China Biopharmaceutical Ltd. WIR Staff...
Items per page:
1 - 4 of 4
BioCentury | Aug 3, 2015
Financial News

Ally Bridge Group financial update

...hedge fund will primarily invest in publicly listed Asian healthcare companies, with a focus on China biopharmaceuticals...
BioCentury | Jun 25, 2012
Company News

NeoStem deal

...is subject to shareholder approval. NeoStem acquired its stake in 2009 through its acquisition of China Biopharmaceuticals Holdings Inc....
BioCentury | Nov 9, 2009
Company News

NeoStem, China Biopharmaceuticals deal

...NeoStem acquired China Biopharmaceuticals, which owns 51% of Suzhou Erye Pharmaceutical Co. Ltd. (Suzhou, China). Suzhou Erye...
...its stem cell therapy, research and development in China. NeoStem Inc. (NYSE-A:NBS), New York, N.Y. China Biopharmaceuticals Holdings Inc....
BioCentury | Oct 15, 2007
Company News

Beijing Med-Pharm management update

Beijing Med-Pharm Corp. (BJGP), Plymouth Meeting, Penn. Business: Supply/Service Hired: Yanping Zhao as corporate VP, formerly VP, executive director and chief representative of the Beijing office at China Biopharmaceutical Ltd. WIR Staff...
Items per page:
1 - 4 of 4